CHU de LILLE
Lille, Hauts-de-France, 59037, France
Location status: Recruiting
Location contact
Sylvie JORIOT, MD
CONTACT
0320445962 ext. +33
Sylvie NGUYEN THE TICH, MD, PhD
CONTACT
320445962 ext. +33
NCT Number: NCT05658965
Congenital cardiopathy are frequent malformations (1/100 birth). The progress of surgery permit a survival rate at the adult age of more than 90%. The long terms consequences must be taken in account and the nerodevelopmental disorders are in first place (intelectual deficiency, autism spectrum disorders, or attention disorders) and presents in 30 to 60% of the patients (Calmant, 2015). The impact can be important on the scolarity, the studies, the professional activity and finaly on the quality of life of the patients becomming adults.
The identification of the risk factors on surgery period should permit to propose the most adapted follow-up to the specifics needs of each patients.
On the scientific plans, the identification of early markers on brain dammage on EEG should permit to better apprehend the physiopathologic mecanisms involved.
Interested in participating?
Request Info1 day–1 year
All sexes
Observational
Lille, Hauts-de-France, 59037, France
Location status: Recruiting
Sylvie JORIOT, MD
CONTACT
0320445962 ext. +33
Sylvie NGUYEN THE TICH, MD, PhD
CONTACT
320445962 ext. +33
Interest of early EEG on congenital cardiopathy surgery to predict the neurodevelopmental disorders occurence.
Congenital cardiopathy are frequent malformations (1/100 birth). The progress of surgery permit a survival rate at the adult age of more than 90%. The long terms consequences must be taken in account and the nerodevelopmental disorders are in first place (intelectual deficiency, autism spectrum disorders, or attention disorders) and presents in 30 to 60% of the patients (Calmant, 2015). The impact can be important on the scolarity, the studies, the professional activity and finaly on the quality of life of the patients becomming adults.
The identification of the risk factors on surgery period should permit to propose the most adapted follow-up to the specifics needs of each patients.
On the scientific plans, the identification of early markers on brain dammage on EEG should permit to better apprehend the physiopathologic mecanisms involved.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Age of patient : 24 Months
Evaluation of the interest of pre and post surgery EEG in the prediction of neurodevelopmental disorders on patients operated of congenital cardiopathy before the age of 1 year old.
Time frame: Age of patient : 24 Months
Association between the presence of pre surgery and 1 year old orality disorder and occurence of neurodevelopmental disorders.
Time frame: Age of patient : 24 Months
Evaluation of the interest of 24 months old post surgery EEG in the prediction of neurodevelopmental disorders on patients operated of congenital cardiopathy before the age of 1 year old, having a normal pre surgery EEG.
Contact information is provided by the study sponsor or research team.
Sylvie JORIOT, MD
CONTACT
0320445962 ext. +33
Sylvie NGUYEN THE TICH, MD,PhD
CONTACT
0320445962 ext. +33
University Hospital, Lille
Other
Intérêt de l'électroencéphalogramme précoce en Chirurgie de Cardiopathie congénitale Pour prédire la Survenue de Troubles du neurodéveloppement
Acronym: KHB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT04096430
Autism Spectrum Disorder, Brain Damage, Chronic
Calgary, Alberta, Canada
View Trial DetailsNCT06776341
GEMIN5 Protein, Human, Mental Disorders
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05432349
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Disease
Birmingham, Alabama, United States
View Trial Details